首页 > 市场调查报告书 > 医疗设备

e保健

市场调查报告书

商品编码

1547713

全球数位治疗市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Digital Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 128 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球数位治疗市场需求预计将从 2023 年的 67.6 亿美元达到 2032 年近 616 亿美元的市场规模，2024-2052 年研究期间复合年增长率为 27.83%。

数位治疗 (DTx) 是一种新的数位医疗保健概念，可为患者提供基于证据的治疗干预措施。 DTx 由高品质软体程式驱动，用于预防、管理或治疗广泛的身体、精神和行为状况。数位疗法增强并支持目前的医学治疗。它为患者、提供者和付款人提供了新颖的治疗选择，以满足未满足的医疗需求，并减少了对传统医疗保健系统或其他疗法的依赖。它可以单独应用或与其他治疗结合应用。

市场动态

预计全球数位治疗市场在预测期内将以指数速度成长。数位化颠覆了所有产业，医疗保健也不例外。行动技术和人工智慧 (AI) 的进步扩大了数位疗法在医疗保健中的作用。患者对数位疗法的认识不断增强，他们的健康状况以及他们在疾病管理中发挥更积极作用的能力创造了潜在的健康结果并减少了传统医疗保健系统的成本。主要参与者正在投资这个概念，并选择与科技公司建立策略伙伴关係来开拓市场。透过合作取得的令人兴奋的进步将创造市场机会。然而，世界某些地区缺乏认识正在阻碍市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球数位治疗市场的每个细分市场进行了包容性评估。数位治疗行业的成长和趋势为这项研究提供了整体方法。

市场区隔

数位治疗市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按申请

糖尿病
肥胖
CVD
呼吸系统疾病
戒烟
中枢神经系统疾病
其他的

按最终用途

患者
供应商
付款人
雇主
其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲数位治疗市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。数位治疗市场的主要参与者包括 Omada Health Inc.、Welldoc Inc.、2Morrow Inc.、Teladoc Health Inc.、Propeller Health (ResMed)、Fitbit LLC、Canary Health、Noom Inc.、Pear Therapeutics Inc.、Akili Interactive Labs Inc.、Hygieia、DarioHealth Corp.、BigHealth、GAIA AG、Limbix Health Inc.、Mango Health。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 8 章：数位治疗公司的竞争格局

数位治疗市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 9 章：公司简介

顶级公司市占率分析
市场集中度
Omada Health Inc.

公司概况
公司收入
产品
最新动态

Welldoc Inc.

公司概况
公司收入
产品
最新动态

2Morrow Inc

公司概况
公司收入
产品
最新动态

Teladoc Health Inc.

公司概况
公司收入
产品
最新动态

Propeller Health (ResMed)

公司概况
公司收入
产品
最新动态

Fitbit LLC

公司概况
公司收入
产品
最新动态

Canary Health

公司概况
公司收入
产品
最新动态

Noom Inc.

公司概况
公司收入
产品
最新动态

Pear Therapeutics Inc.

公司概况
公司收入
产品
最新动态

Akili Interactive Labs Inc.

公司概况
公司收入
产品
最新动态

Hygieia

公司概况
公司收入
产品
最新动态

DarioHealth Corp.

公司概况
公司收入
产品
最新动态

BigHealth

公司概况
公司收入
产品
最新动态

GAIA AG

公司概况
公司收入
产品
最新动态

Limbix Health Inc.

公司概况
公司收入
产品
最新动态

Mango Health

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11213684

The global demand for Digital Therapeutics Market is presumed to reach the market size of nearly USD 61.6 Billion by 2032 from USD 6.76 Billion in 2023 with a CAGR of 27.83% under the study period 2024-2052.

Digital therapeutics (DTx) is a new digital healthcare concept that delivers evidence-based therapeutic interventions to patients. DTx is driven by high-quality software programs to prevent, manage, or treat a broad spectrum of physical, mental, and behavioral conditions. Digital therapeutics enhance and support current medical treatments. It provides patients, providers, and payers with novel therapy options for unmet medical needs and reduces reliance on traditional healthcare system or other therapies. It can be applied independently or in conjunction with other treatments.

MARKET DYNAMICS

The global digital therapeutics market is forecast to grow at an exponential rate during the forecast period. Digitalization has disrupted all the sectors, and healthcare is not an exception. Advances in mobile technology and artificial intelligence (AI) have broadened the role of digital therapeutics in healthcare. Growing awareness about digital therapeutics among patients of their health and their ability to play a more active role in managing their disease create potential health outcomes and reduce traditional healthcare systems expenses. Key players are investing in the concept and opting for strategic partnerships with tech companies to explore the market. The exciting advancement through collaboration will create market opportunities. However, lack of awareness in some parts of the world is hampering the growth of the market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Digital Therapeutics. The growth and trends of Digital Therapeutics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Digital Therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Application

Diabetes
Obesity
CVD
Respiratory Diseases
Smoking Cessation
CNS Diseases
Others

By End-use

Patients
Providers
Payers
Employers
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Digital Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Digital Therapeutics market include Omada Health Inc., Welldoc Inc., 2Morrow Inc, Teladoc Health Inc., Propeller Health (ResMed), Fitbit LLC, Canary Health, Noom Inc., Pear Therapeutics Inc., Akili Interactive Labs Inc., Hygieia, DarioHealth Corp., BigHealth, GAIA AG, Limbix Health Inc., Mango Health. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. DIGITAL THERAPEUTICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Application
- 3.7.2 Market Attractiveness Analysis By End-use
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL DIGITAL THERAPEUTICS MARKET ANALYSIS BY APPLICATION

5.1. Overview By Application
5.2. Historical and Forecast Data
5.3. Analysis By Application
5.4. Diabetes Historic and Forecast Sales By Regions
5.5. Obesity Historic and Forecast Sales By Regions
5.6. CVD Historic and Forecast Sales By Regions
5.7. Respiratory Diseases Historic and Forecast Sales By Regions
5.8. Smoking Cessation Historic and Forecast Sales By Regions
5.9. CNS Diseases Historic and Forecast Sales By Regions
5.10. Others Historic and Forecast Sales By Regions

6. GLOBAL DIGITAL THERAPEUTICS MARKET ANALYSIS BY END-USE

6.1. Overview By End-use
6.2. Historical and Forecast Data
6.3. Analysis By End-use
6.4. Patients Historic and Forecast Sales By Regions
6.5. Providers Historic and Forecast Sales By Regions
6.6. Payers Historic and Forecast Sales By Regions
6.7. Employers Historic and Forecast Sales By Regions
6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL DIGITAL THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE DIGITAL THERAPEUTICS COMPANIES

8.1. Digital Therapeutics Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF DIGITAL THERAPEUTICS INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Omada Health Inc.
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Welldoc Inc.
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. 2Morrow Inc
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Teladoc Health Inc.
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Propeller Health (ResMed)
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Fitbit LLC
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. Canary Health
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Noom Inc.
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Pear Therapeutics Inc.
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. Akili Interactive Labs Inc.
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments
9.13. Hygieia
- 9.13.1 Company Overview
- 9.13.2 Company Revenue
- 9.13.3 Products
- 9.13.4 Recent Developments
9.14. DarioHealth Corp.
- 9.14.1 Company Overview
- 9.14.2 Company Revenue
- 9.14.3 Products
- 9.14.4 Recent Developments
9.15. BigHealth
- 9.15.1 Company Overview
- 9.15.2 Company Revenue
- 9.15.3 Products
- 9.15.4 Recent Developments
9.16. GAIA AG
- 9.16.1 Company Overview
- 9.16.2 Company Revenue
- 9.16.3 Products
- 9.16.4 Recent Developments
9.17. Limbix Health Inc.
- 9.17.1 Company Overview
- 9.17.2 Company Revenue
- 9.17.3 Products
- 9.17.4 Recent Developments
9.18. Mango Health
- 9.18.1 Company Overview
- 9.18.2 Company Revenue
- 9.18.3 Products
- 9.18.4 Recent Developments